Marpai, Inc. (MRAI): Nasdaq/NYSE listing notice — Marpai receives Nasdaq bid price deficiency notice; 180-day cure period to April 3, 2024

Marpai, Inc.

Received Nasdaq notice on Oct 6, 2023 for failing to maintain minimum $1.00 bid price for 30 consecutive business days.
Must regain compliance by April 3, 2024 by closing at $1.00+ for at least 10 consecutive business days.
If not cured, may seek additional 180-day period if it meets other listing standards and intends to cure via reverse stock split.
Company will monitor bid price but cannot assure compliance will be regained.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Marpai, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

October 6, 2023, Marpai, Inc. (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company did not satisfy the requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”) to maintain a minimum bid price of $1.00 per share. The Company became deficient with Rule 5550(a)(2) as of October 6, 2023 as the closing bid price of its Class A common stock was less than $1.00 per share for 30 consecutive business days prior to the date o

View on SEC.gov

Browse all listing & compliance notices →

Marpai, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-052392

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.